Equalizing Prognostic Disparities in Stage III KRAS-mutant NSCLC: Addition of Durvalumab to Combined Chemoradiotherapy Improves SurvivalElla A Eklund, Mathilda Orgard, Delice Wallin,Sama I Sayin,Henrik Fagman,Sukanya Raghavan,Levent M Akyurek,Jan Nyman,Clotilde Wiel,Andreas Hallqvist,Volkan I Sayincrossref（2024）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
